Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds. | Pharmaceuticals (Basel) | 2023 | 37513880 | PubTator, text mining | PubMed |
| Natural Flavonoids Quercetin and Kaempferol Targeting G2/M Cell Cycle-Related Genes and Synergize with Smac Mimetic LCL-161 to Induce Necroptosis in Cholangiocarcinoma Cells. | Nutrients | 2023 | 37513508 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023). | Molecules | 2023 | 37513440 | PubTator, text mining | PubMed |
| NOXA Accentuates Apoptosis Induction by a Novel Histone Deacetylase Inhibitor. | Cancers (Basel) | 2023 | 37509312 | PubTator, text mining | PubMed |
| HDAC-an important target for improving tumor radiotherapy resistance. | Front Oncol | 2023 | 37503317 | PubTator, text mining | PubMed |
| Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities. | Nat Struct Mol Biol | 2023 | 37488358 | PubTator, text mining | PubMed |
| WeiTsing: A guard of the stele. | Mol Plant | 2023 | 37480228 | PubTator, text mining | PubMed |
| Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis. | Reprod Med Biol | 2023 | 37476367 | PubTator, text mining | PubMed |
| Histone deacetylase III interactions with BK polyomavirus large tumor antigen may affect protein stability. | Virol J | 2023 | 37464367 | PubTator, text mining | PubMed |
| Discovery of HDAC6, HDAC8, and 6/8 Inhibitors and Development of Cell-Based Drug Screening Models for the Treatment of TGF-β-Induced Idiopathic Pulmonary Fibrosis. | J Med Chem | 2023 | 37463500 | PubTator, text mining | PubMed |
| Integrated multiomic analysis and high-throughput screening reveal potential gene targets and synergetic drug combinations for osteosarcoma therapy. | MedComm (2020) | 2023 | 37457661 | PubTator, text mining | PubMed |
| Continuous enzyme activity assay for high-throughput classification of histone deacetylase 8 inhibitors. | Explor Target Antitumor Ther | 2023 | 37455831 | PubTator, text mining | PubMed |
| Nasal polyposis in pediatric patients with Cornelia de Lange syndrome: endoscopic diagnosis, treatment and follow up in two case reports. | Ital J Pediatr | 2023 | 37455311 | PubTator, text mining | PubMed |
| Transcriptome analysis identifies the role of Class I histone deacetylase in Alzheimer's disease. | Heliyon | 2023 | 37449137 | PubTator, text mining | PubMed |
| Electrochemical Synthesis of New Isoxazoles and Triazoles Tethered with Thiouracil Base as Inhibitors of Histone Deacetylases in Human Breast Cancer Cells. | Molecules | 2023 | 37446915 | PubTator, text mining | PubMed |
| PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation. | Biol Direct | 2023 | 37434235 | PubTator, text mining | PubMed |
| Are inhibitors of histone deacetylase 8 (HDAC8) effective in hematological cancers especially acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)? | Eur J Med Chem | 2023 | 37429084 | PubTator, text mining | PubMed |
| Cortical type: a conceptual tool for meaningful biological interpretation of high-throughput gene expression data in the human cerebral cortex. | Front Neuroanat | 2023 | 37426901 | PubTator, text mining | PubMed |
| Targeting histone deacetylases for cancer therapy: Trends and challenges. | Acta Pharm Sin B | 2023 | 37425042 | PubTator, text mining | PubMed |
| Tropolones and Thailandepsin B as Lead-like Natural Compounds in the Development of Potent and Selective Histone Deacetylase Inhibitors. | Curr Drug Targets | 2023 | 37424350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=17